This BAA supports research in the fields of chemical, biological, radiological and nuclear defense/countermeasures. Studies related to novel solutions and improved methods to develop medical countermeasures more rapidly and with increased efficiency through enabling technologies, life cycle bioinformatics, and improved logistics tracking are of specific interest.
Submissions are invited from educational institutions, non-profit organisations and private industry, within and outside the US.
Areas of interest include:
- late-stage therapeutics & platform vaccines
- medical countermeasure drug capabilities
- therapeutic solutions
- technologies to enable early warning, identification and continual situation awareness of potential global health threats
Preproposals accepted on an ongoing basis to 11 June 2027 –
